FIGURE

Figure 1

ID

ZDB-FIG-250417-134

Publication

Minoia et al., 2025 - Antioxidant, Osteogenic, and Neuroprotective Effects of Homotaurine in Aging and Parkinson's Disease Models

Other Figures

All Figure Page

Back to All Figure Page

Figure 1

Assessment of ROS levels, MSC viability, and the effect of homotaurine treatment during a 14-day period. (A) A significant increase in reactive oxygen species (ROS) levels was observed starting from day 3, suggesting a correlation between elevated ROS and cellular aging in mesenchymal stem cells (MSCs). (B) No significant differences in cell viability were noted after 3 days of culture, while a marked improvement in cell viability was observed on day 14. (C) This cell viability increase was associated with a reduction in ROS levels following homotaurine treatment, also on day 14, with no previous alteration after 3 days of treatment. (* p < 0.05; ** p < 0.01; *** p < 0.005).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Antioxidants (Basel)